|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:founded
|
1991
|
|
gptkbp:founder
|
gptkb:Walter_Gilbert
gptkb:Dennis_W._Farrington
gptkb:John_M._Dunn
gptkb:Mark_Skolnick
gptkb:Peter_Meldrum
gptkb:Kevin_Judice
|
|
gptkbp:headquartersLocation
|
gptkb:Salt_Lake_City,_Utah,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Myriad Genetics
|
|
gptkbp:industry
|
gptkb:biotechnology
|
|
gptkbp:keyPerson
|
gptkb:Paul_J._Diaz
|
|
gptkbp:notableEvent
|
involved in Supreme Court case Association for Molecular Pathology v. Myriad Genetics, Inc.
|
|
gptkbp:notableFor
|
BRCA1 and BRCA2 gene testing
|
|
gptkbp:numberOfEmployees
|
approximately 2,700 (2023)
|
|
gptkbp:product
|
genetic testing
diagnostic tests
|
|
gptkbp:servesArea
|
worldwide
|
|
gptkbp:specialty
|
oncology
women's health
molecular diagnostics
personalized medicine
autoimmune diseases
|
|
gptkbp:stockExchange
|
gptkb:NASDAQ
|
|
gptkbp:stockSymbol
|
gptkb:MYGN
|
|
gptkbp:tradedOn
|
gptkb:NASDAQ:_MYGN
|
|
gptkbp:website
|
https://www.myriad.com/
|
|
gptkbp:bfsParent
|
gptkb:Walter_Gilbert
|
|
gptkbp:bfsLayer
|
6
|